Approaches for genetic manipulation of Naegleria fowleri
Approaches for genetic manipulation of Naegleria fowleri
批准号:
10641130
负责人:
JAMES Culvin MORRIS
金额:
$19.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-09 至 2024-12-31
关键词:
AblationAddressAllelesAmoeba genusAreaAwarenessBasic ScienceBindingBiologyBrainCRISPR/Cas technologyCategoriesCell LineClassificationDetectionDevelopmentDrug TargetingGene ExpressionGene SilencingGene Transfer TechniquesGenerationsGenesGeneticGoalsInfectionInvadedLifeMediatingMolecularMutagenesisNaegleriaNaegleria fowleriNational Institute of Allergy and Infectious DiseaseNoseOrganismOutcomeParasitesPathogenicityPathway interactionsPharmacotherapyPhenotypeProcessProteinsRNA InterferenceReactionReagentResistanceTechnologyTherapeuticTherapeutic AgentsTransgenic OrganismsValidationWorkchemical geneticscontaminated waterdrug developmentdrug discoverydruggable targetfightinggene functiongenetic approachgenetic manipulationinhibitorinterestknockout geneloss of functionmortalitynovel strategiesnovel therapeuticsoverexpressionpathogenprimary amebic meningoencephalitispromotertargeted treatmenttherapeutic targettooltransgene expressionvector
中文摘要
项目摘要
该提案的目标是开发分子工具和方法,用于研究
致病性自由生活的福氏耐格里阿米巴。目前不存在这些。这个变形虫
是原发性阿米巴脑膜脑炎(PAM)的病原体,
致命的脑部感染缺乏治疗这种感染的有效药物,
需要开发更好的治疗阿米巴感染的药物。缺乏
了解寄生虫的基因功能仍然是靶向药物的主要障碍
发展运动。在这里,我们建议通过开发
通过RNAi和CRISP/Cas9介导的基因编辑进行基因沉默和消融的方法
和转基因表达。这些方法将作为重要的第一步,
了解基因功能和重要性,这是早期药物发现工作的关键。
英文摘要
Project Summary
The goal of this proposal is to develop molecular tools and approaches for the study of the
pathogenic free-living amoeba Naegleria fowleri. These currently do not exist. This amoeba
is the causative agent of primary amebic meningoencephalitis (PAM), an almost invariable
lethal brain infection. The lack of useful drugs for the treatment of this infection emphasizes
the need to develop better therapeutic agents for amoebae infections. The lack of
understanding of gene function in the parasite remains a major hurdle in target-based drug
development campaigns. Here, we propose to address this problem by developing
approaches for gene silencing and ablation by RNAi and CRISP/Cas9-mediate gene editing
and transgene expression. These approaches will serve as an important first step in
understanding both gene function and essentiality, key to early-stage drug discovery efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
-
批准号:10739388
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2023
-
负责人:JAMES Culvin MORRIS
-
依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
-
批准号:10494462
-
项目类别:
-
资助金额:$220.95万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
-
批准号:10666653
-
项目类别:
-
资助金额:$221.43万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
-
批准号:10798537
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient sensing and hexokinases in T. brucei
-
批准号:7911534
-
项目类别:
-
资助金额:$1.14万
-
财政年份:2009
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient Sensing and Hexokinases in T. brucei
-
批准号:8229951
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2008
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient sensing and hexokinases in T. brucei
-
批准号:7454845
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2008
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Identification of Inhibitors of Trypanosoma Brucei Hexokinases
-
批准号:7459260
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Glucose Sensing and Hexokinases in the African Trypanosome
-
批准号:9900822
-
项目类别:
-
资助金额:$22.11万
-
财政年份:--
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Glucose Sensing and Hexokinases in the African Trypanosome
-
批准号:9261578
-
项目类别:
-
资助金额:$24.31万
-
财政年份:--
-
负责人:JAMES Culvin MORRIS
-
依托单位:
海外基金